|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
SCIDIR_ocn568141715 |
003 |
OCoLC |
005 |
20231117032951.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
100324s1987 flua ob 001 0 eng d |
040 |
|
|
|a OCLCE
|b eng
|e pn
|c OCLCE
|d OCLCQ
|d OPELS
|d E7B
|d N$T
|d OCLCO
|d IDEBK
|d OCLCQ
|d UIU
|d YDXCP
|d EBLCP
|d DEBSZ
|d OCLCQ
|d UAB
|d OCLCQ
|d MERUC
|d OCLCQ
|d OCLCO
|d OCLCA
|d OCLCQ
|d LEAUB
|d OCLCO
|d OCLCQ
|d OCLCA
|d OCLCO
|d OCLCQ
|
019 |
|
|
|a 603989563
|a 850150470
|
020 |
|
|
|a 9780323152327
|q (electronic bk.)
|
020 |
|
|
|a 0323152325
|q (electronic bk.)
|
020 |
|
|
|z 9780124818354
|
020 |
|
|
|z 0124818358
|
035 |
|
|
|a (OCoLC)568141715
|z (OCoLC)603989563
|z (OCoLC)850150470
|
042 |
|
|
|a dlr
|
050 |
|
4 |
|a QP801.P638
|b I55 1987
|
060 |
|
4 |
|a QU 60
|b I55 1987
|
072 |
|
7 |
|a MED
|x 067000
|2 bisacsh
|
082 |
0 |
4 |
|a 574.2/192
|2 22
|
245 |
0 |
0 |
|a Inhibition of polyamine metabolism :
|b biological significance and basis for new therapies /
|c edited by Peter P. McCann, Anthony E. Pegg, Albert Sjoerdsma.
|
260 |
|
|
|a Orlando :
|b Academic Press,
|c 1987.
|
300 |
|
|
|a 1 online resource (xvi, 371 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references and index.
|
538 |
|
|
|a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.
|u http://purl.oclc.org/DLF/benchrepro0212
|5 MiAaHDL
|
583 |
1 |
|
|a digitized
|c 2010
|h HathiTrust Digital Library
|l committed to preserve
|2 pda
|5 MiAaHDL
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a Front Cover; Inhibition of Polyamine Metabolism: Biological Significance and Basis for New Therapies; Copyright Page; Table of Contents; Preface; Introduction: Polyamine Metabolism; Chapter 1. Inhibition of Basic Amino Acid Decarboxylases Involved in Polyamine Biosynthesis; I. Introduction; II. Properties of ODC; III. Mechanism of Action of ODC; IV. Inhibition of ODC; V. Inhibition of Arginine Decarboxylase and Lysine Decarboxylase; VI. Conclusion; References; Chapter 2. Pharmacologic Interference with Enzymes of Polyamine Biosynthesis and of 5'-Methylthioadenosine Metabolism; I. Introduction.
|
505 |
8 |
|
|a II. S-Adenosylmethionine Decarboxylase (AdoMetDC)III. Spermidine Synthase; IV. Spermine Synthase; V. Enzymatic Degradation of 5'-Methylthioadenosine (MTA); References; Chapter 3. Inhibition of Enzymes Oxidizing Polyamines; I. Introduction; II. Copper Amine Oxidases; III. Flavin-Dependent Enzymes in Polyamine Catabolism; IV. Biological Consequences of Polyamine Oxidase Inactivation; V. Conclusions; References; Chapter 4. Molecular and Cellular Functions of the Polyamines; I. Introduction; II. Nucleic Acid Structure; III. Macromolecular Synthesis; IV. Topoisomerase Activity.
|
505 |
8 |
|
|a v. Membrane Structure and FunctionAcknowledgments; References; Chapter 5. The Use of Inhibitors to Study the Biochemistry and Molecular Biology of Polyamine Biosynthesis and Uptake; I. Introduction; II. Studies of Ornithine Decarboxylase; III. Studies of S-Adenosylmethionine Decarboxylase (AdoMetDC); IV. Studies of Polyamine Transport; References; Chapter 6. Inhibitors of Polyamine Biosynthesis: Cellular and in Vivo Effects on Tumor Proliferation; I. Introduction; II. Polyamine Biosynthesis in Normal and Transformed Cells; III. Inhibitors of Polyamine Biosynthesis.
|
505 |
8 |
|
|a IV. Cellular Effects of Polyamine InhibitorsV. Polyamine Inhibitors: In Vivo Effects against Experimental Tumors; VI. Summary; References; Chapter 7. Polyamine Inhibition in Vivo and in Organ Growth and Repair; I. Introduction; II. In Vivo Biochemistry of Polyamine Biosynthesis Inhibitors; III. Consequences of Polyamine Inhibition on Organ Growth and Repair; IV. Conclusions; References; Chapter 8. Polyamine Synthesis Inhibitors Act as both Inducers and Suppressors of Cell Differentiation; I. Introduction; II. Germ Cells and Embryos; III. Organ Systems.
|
505 |
8 |
|
|a IV. Primary Cell Cultures and Established Cell LinesV. Summary and Future Prospects; Acknowledgments; References; Chapter 9. The Contragestational Effects of Ornithine Decarboxylase Inhibition; I. Introduction; II. Polyamine Biochemical Changes during Gestation in Mammals; III. Effects of Inhibitors of ODC on Gestation; IV. Clinical Significance of the Contragestational Effects of ODC Inhibition; V. Conclusion; References; Chapter 10. Modulation of Antineoplastic Drug Action by Inhibitors of Polyamine Biosynthesis; I. Introduction; II. Goals of Combination Chemotherapy.
|
520 |
|
|
|a Inhibition of polyamine metabolism.
|
650 |
|
0 |
|a Polyamines
|x Synthesis
|x Inhibitors
|x Physiological effect.
|
650 |
|
0 |
|a Polyamines
|x Synthesis
|x Inhibitors
|x Therapeutic use.
|
650 |
|
0 |
|a Polyamines
|x Metabolism
|x Regulation.
|
650 |
|
2 |
|a Polyamines
|x metabolism
|0 (DNLM)D011073Q000378
|
650 |
|
6 |
|a Polyamines
|0 (CaQQLa)201-0058116
|x Synth�ese
|0 (CaQQLa)201-0374877
|x Inhibiteurs
|0 (CaQQLa)201-0374877
|x Effets physiologiques.
|0 (CaQQLa)201-0374337
|
650 |
|
6 |
|a Polyamines
|0 (CaQQLa)201-0058116
|x Synth�ese
|0 (CaQQLa)201-0374877
|x Inhibiteurs
|0 (CaQQLa)201-0374877
|x Emploi en th�erapeutique.
|0 (CaQQLa)201-0373975
|
650 |
|
6 |
|a Polyamines
|0 (CaQQLa)201-0058116
|x M�etabolisme
|0 (CaQQLa)201-0379671
|x R�egulation.
|0 (CaQQLa)201-0379671
|
650 |
|
7 |
|a MEDICAL
|x Pathology.
|2 bisacsh
|
653 |
|
|
|a Organisms
|a Polyamines
|a Biosynthesis
|a Inhibitors
|
700 |
1 |
|
|a McCann, Peter P.
|
700 |
1 |
|
|a Pegg, Anthony E.
|
700 |
1 |
|
|a Sjoerdsma, Albert,
|d 1924-
|
776 |
0 |
8 |
|i Print version:
|t Inhibition of polyamine metabolism.
|d Orlando : Academic Press, 1987
|z 9780124818354
|w (DLC) 86032147
|w (OCoLC)15016944
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780124818354
|z Texto completo
|